All News

Study results suggest a nationwide increase in the supply and availability of illicitly manufactured fentanyl, with pills becoming more dominant across the ever-shifting US fentanyl market.

In Germany, data live in the cloud, patients can fill prescriptions at any pharmacy, and the wholesale price of semaglutide (Ozempic) is a fraction of the cost.

In case you missed it, this week we had news about pharmacy issues in the election spotlight, advancements in psychedelic therapeutics, prior authorization, and more.

Check out important updates from the FDA for the week of May 6.

The company, which operates 140 care sites across the country, was forced to shut down health systems earlier this week because of the disruption.

Test your pharmacy news knowledge with our weekly quiz.

Dive in and learn more about the answers to yesterday’s quiz.

Since biosimilars first launched, unique pricing incentives and strategies have been created to incentives adoption.

A single dose of Compass Pathways’ investigational COMP360 was well tolerated and showed durable improvements in CAPS-5 and SDS total scores compared to baseline.

Researchers analyzed the prior authorization requirements of private insurers applied to various Medicare services.

Test your knowledge of allergy and asthma clinical guidelines.

Designs of existing wearables overlook the specific needs of vulnerable populations, hindering their widespread adoption among increasingly interested communities.

Check out this list of resources to share with patients who are experiencing mental health conditions.

As demand for GLP-1 receptor agonist medications increases, researchers are hopeful these drugs can be used for more indications than those that currently exist.

Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.

For National Fentanyl Awareness Day, Drug Topics talked with Scott H. Silverman about how public health leaders can address the fentanyl crisis and the best ways to educate the public on the dangers of fentanyl use.

The Psychopharmacologic Drugs Advisory Committee will meet June 4 to review a new drug application from Lykos Therapeutics.

The specialty drug market has exploded in the last few decades.

As medication experts, pharmacists can advocate to organizational decision makers around the benefits of biosimilars.

Data from 2024 are being used as a way to predict what changes may be on the way for 2025.

Mycophenolate mofetil oral suspension is the only FDA-approved ready-to-use liquid formulation.

Researchers continue to report on the rise of syphilis in the US, with recent cases exhibiting rare symptoms in the eyes, ears, and brain.

In case you missed it, this week we had news about marijuana reclassification, the Change Healthcare cyberattack, declining wages among community pharmacists, and more.

Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.

Check out important updates from the FDA for the week of April 29.

Two trials studying brexpiprazole in combination with sertraline "constitute one of the largest clinical development programs ever conducted in posttraumatic stress disorder (PTSD)."

Are you a Wookie with a mane to maintain or a scoundrel prone to nausea? You don’t have to traverse distant planets to find OTC recommendations that meet your needs—this guide has you covered.

A siloed approach to care can worsen patient outcomes, but collaboration between one health system specialty pharmacy and a manufacturer led to better patient care.